Advertisement

Topics

Midas Pharma GmbH Company Profile

01:02 EDT 19th June 2018 | BioPortfolio

April 1988 Foundation of Midas Pharmachemie GmbH November 1992 First participation in the CPhI in Wiesbaden
May 1996 Foundation of Midas Chimie Fine in France
July 1996 Start of the development of pharmaceutical dossiers
May 1998 First sales of finished pharmaceutical products
January 1999 Inauguration of a liaison office in Beijing, China

Location

Rheinstraße 49
Ingelheim
55218
Germany

Contact

Phone: 49.61 32.9 90-0
Fax: 49.61 32.9 90-40
Email: info@midas-pharma.com


News Articles [886 Associated News Articles listed on BioPortfolio]

DGAP-News: Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz

Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz Deutschland/Hexal DGAP-News: Novartis Pharma GmbH / Schlagwort(e): Sonstiges Nov...

Heidelberg Pharma schließt Lizenzvertrag mit Universität von Texas MD Anderson Cancer Center ab

Bad Marienberg - Die Heidelberg Pharma AG (ISIN DE000A11QVV0/ WKN A11QVV) gab heute den Abschluss eines Lizenzvertrags zwischen ihrer Tochtergesellschaft Heidelberg Pharma Research GmbH und der Uni...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 16022018] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Heidelberg Pharma: Lizenz- und Forschungsdeal mit Magenta Therapeutics

Heidelberg Pharma hat mit Magenta Therapeutics eine Kooperation im Bereich der Wirkstoffforschung vereinbart. "Heidelberg Pharma Research GmbH unterzeichnete die Vereinbarung, bei der aus Magentas ...

DGAP-Adhoc: CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich (deutsch)

CO.DON AG: CO.DON AG zeichnet Term Sheet mit der Haemo Pharma GmbH über den Vertrieb von Spherox in Österreich DGAP-Ad-hoc: CO.DON AG / Schlagwort(e): Markteinführung CO.DON AG: CO.DON AG zeichnet....

Systec GmbH Introduces its new Business Partner Evidencia GmbH

Research, pharmaceuticals, life sciences and food: many laboratories rely on steam sterilizers or equipment where processes are monitored using pressure and temperature control. Thanks to our collabor...

Heidelberg Pharma and Magenta Therapeutics Sign Exclusive Multi-Target Research Agreement

Heidelberg Pharma AG and Magenta Therapeutics Inc., a biotechnology company developing therapeutics to improve and extend the use of curative bone marrow transplant for more patients, announced the si...

Onconova grants Latin American rigosertib rights to Pint Pharma

Onconova Therapeutics Inc. granted Pint Pharma GMBH exclusive rights to sell rigosertib in Latin America.

PubMed Articles [38 Associated PubMed Articles listed on BioPortfolio]

Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.

Photodynamic diagnosis using the optical imaging agent hexaminolevulinate (HAL, Hexvix®, Ipsen Pharma GmbH, Ettlingen, Germany) as an adjunct to white light cystoscopy (WLC) during the initial transu...

MIDAS: A modular DNA assembly system for synthetic biology.

A modular and hierarchical DNA assembly platform for synthetic biology based on Golden Gate (Type IIS restriction enzyme) cloning is described. This enabling technology, termed MIDAS (for Modular Idem...

Forecasting carbon dioxide emissions based on a hybrid of mixed data sampling regression model and back propagation neural network in the USA.

The accurate forecast of carbon dioxide emissions is critical for policy makers to take proper measures to establish a low carbon society. This paper discusses a hybrid of the mixed data sampling (MID...

Cross-cultural adaptation of the Myocardial Infarction Dimensional Assessment Scale (MIDAS) to the Brazilian Portuguese language.

From the evaluation of the factors that affect quality of life (QOL) it is possible to plan interventions that lead to the improved well-being of patients. The scope of this study was to conduct the c...

Moving pharma contracting into the era of accountability.

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Using Focus Groups to Assess the Impact of Environmental Health Science Programs for K-12 Educational Community

The MIDAS Project (Models of Implementation and Dissemination of Environmental Health and Science Across Subjects) Assessment Objectives: - Determine whether students are aware of the ...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Subjects

The purpose of this trial is to compare the pharmacokinetic characteristics of two isosorbide -5 -mononitrate extended -release tablets 40 mg of Qilu Pharmaceutical Co., Ltd and ISMO Retar...

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

Companies [1248 Associated Companies listed on BioPortfolio]

Midas Pharma GmbH

April 1988 Foundation of Midas Pharmachemie GmbH November 1992 First participation in the CPhI in Wiesbaden May 1996 Foundation of Midas Chimie Fine in France July 1996 Start of the development of...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

INJEX Pharma AG

INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...

CROMA-PHARMA GmbH

CROMA-PHARMA is a family owned, internationally orientated pharmaceutical company, based in Korneuburg, Austria. CROMA-PHARMA´s areas of activity are orthopedics, ophthalmology...

Ratiopharm

On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm Gm...

More Information about "Midas Pharma GmbH" on BioPortfolio

We have published hundreds of Midas Pharma GmbH news stories on BioPortfolio along with dozens of Midas Pharma GmbH Clinical Trials and PubMed Articles about Midas Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Midas Pharma GmbH Companies in our database. You can also find out about relevant Midas Pharma GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record